India Norfloxacin Market to grow at a steady rate During the Forecast Period
Growing urinary tract
infections amongst population is expected to drive the growth of India
norfloxacin market during the forecast period.
According
to TechSci Research report, “India Norfloxacin Market By Product Type
(Prescription v/s OTC), By Source (In-house v/s Contract Manufacturing
Organizations), By Form (Tablet, Capsule, Eye drops, Syrup, Ointment and
Injection), By Route of Administration (Oral, Intravenous, Topical, Ophthalmic),
By Distribution Channel (Online v/s Offline), By Application (Urinary tract
Infections, Gynaecological Infections, Bladder Infections, Inflammation Of The
Prostate Gland, Gonorrhoea And Others), By End User (Adult v/s Paediatric), By
Company, By Region, Forecast & Opportunities, FY2027”, the India norfloxacin market is expected to grow at a significant
pace during the forecast period on account of growing high prevalence of
chronic diseases in the country. Norfloxacin is a broad-spectrum antibiotic
agent that is known to be effective against various gram-positive and gram-negative
bacterial species. Increase in number of pharmaceutical manufacturers in the
country is creating growth opportunities for norfloxacin market over the
forecast period. Development of novel combination therapies by R&D
processes for treating antibiotic-resistant microbial infections is expected to
fuel the market growth through FY2027. Favorable government policies is
expected to drive the market growth in the forthcoming years. However, development
of drug-resistant strains can restrict the market growth over the next few
years. Norfloxacin is ineffective against viral infections. Also, the side
effects associated with the use of antibiotic such as gastrointestinal effects
including nausea, vomiting, and diarrhea, as well as headache and insomnia, can
act as major impediments to the growth of India norfloxacin market during the
forecast period.
Browse
XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC
on "
India Norfloxacin Market"
https://www.techsciresearch.com/report/india-norfloxacin-market/7316.html
The India norfloxacin market is segmented based on product type, source, form, route of
administration, distribution channel, application, end user,
company, and region. Based on distribution channel, the market can be
fragmented into online v/s offline. The offline channel is expected to dominate
the market which is attributable to several benefits it offers such as consumers
can inspect and examine merchandise by themselves. The online segment is also
expected to register significant growth over the next few years. This can be
ascribed to the development of numerous online pharmacies and doorstep drug
delivery in the country.
Alkem Laboratories Ltd., Aristo
Pharmaceuticals Ltd., Hetero Healthcare Ltd., Taurus Laboratories Pvt. Ltd.,
Alembic Ltd., Ranbaxy Laboratories Ltd., Cipla Ltd., Dr. Reddy’s Laboratories
Ltd., IPCA Laboratories Ltd., Emcure
Pharmaceuticals Ltd., and others are some of the leading players operating
in India norfloxacin market. The key market players operating in the market are
using organic strategies such as product launches, mergers and acquisitions, research
collaborations, joint ventures to boost their market share and to expand their
geographic reach. Along with this, supportive policy for the pharmaceutical
industry is anticipated to aid the current market of Norfloxacin.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7316
Customers can also
request for 10% free customization on this report.
“India norfloxacin market is expected to
witness significant growth in the next 5 years on account of increased number
of bacterial infections. Furthermore, continuous research and development to
exploit the drugs full potential is further expected to fuel the market growth
through FY2027. Also, the drug is also used to treat gynaecological infections
which is another key factor that is expected to create lucrative opportunities
for the market growth over the next five years.” said Mr. Karan
Chechi, Research Director with TechSci Research, a research based India
management consulting firm.
“India Norfloxacin Market By Product Type
(Prescription v/s OTC), By Source (In-house v/s Contract Manufacturing
Organizations), By Form (Tablet, Capsule, Eye drops, Syrup, Ointment and
Injection), By Route of Administration (Oral, Intravenous, Topical, Ophthalmic),
By Distribution Channel (Online v/s Offline), By Application (Urinary tract
Infections, Gynaecological Infections, Bladder Infections, Inflammation Of The
Prostate Gland, Gonorrhoea And Others), By End User (Adult v/s Paediatric), By
Company, By Region, Forecast & Opportunities, FY2027”, has evaluated the future growth potential of India norfloxacin
market and provides statistics & information on market size, structure and
future market growth. The report intends to provide cutting-edge market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in India norfloxacin market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Web: https://www.techsciresearch.com/